Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy

Journal of Laboratory and Clinical Medicine

Volumn 142, Issue 2, 2003, Pages 83-89

  Laurita, Kenneth R ^a   Chuck, Emil Thomas ^b   Yang, Tianen ^b   Dong, Wei Qiang ^b   Kuryshev, Yuri A ^b   Brittenham, Gary M ^b   Rosenbaum, David S ^b   Brown, Arthur M ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; GERBIL; HEART ARRHYTHMIA; HEART CONDUCTION; HEART MUSCLE POTENTIAL; IRON OVERLOAD; ISOLATED HEART; NONHUMAN; PR INTERVAL; QRS COMPLEX; SODIUM CURRENT; THALASSEMIA MAJOR;

EID: 0141630335     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00060-X     Document Type: Article

References (41)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamerini MR, et aI. Survival and disease complications in thalassemia major. Ann N Y Acad Sci 1998;850:227-31.
2. Jensen PD, Olsen N, Bagger JP, Jensen FT, Christensen T, Ellegaard J. Cardiac function during iron chelation therapy in adult non-thalassemic patients with transfusional iron overload. Eur J Haematol 1997;59:221-30.
3. Rivard SR, Mura C, Simard H, Simard R, Grimard D, Le Gac G, et al. Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, Canada). Blood Cell Mol Dis 2000;26:10-4.
4. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 2001;154:193-206.
5. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists: hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
6. Furth PA, Futterweit W, Gorlin R. Refractory biventricular failure in secondary hemochromatosis. Am J Med Sci 1985;290:209-13.
7. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood 2000;95:1229-36.
8. Engle MA, Erlandson M, Smith CH. Late cardiac compilations of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964;30:698-705.
9. Kaye SB, Owen M. Cardiac arrhythmias in thalassemia major: evaluation of chelation treatment using ambulatory monitoring. Br Med J 1978;1:342.
10. Rosenqvist M, Hultcrantz R. Prevalence of a haemochromatosis among men with clinically significant bradyarrhythmias. Eur Heart J 1989;10:473-8.
11. Strobel JS, Fuisz AR, Epstein AE, Plumb VJ. Syncope and inducible ventricular fibrillation in a woman with hemochromatosis. J Interv Card Electrophysiol 1999;3:225-9.
12. Politi A, Sticca M, Galli M. Reversal of haemochromatotic cardiomyopathy in beta thalassemia by chelation therapy. Br Heart J 1995;73:486-7.
13. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993;103:1276-8.
14. Cutler DJ, Isner JM, Bracey AW, Hufnagel CA, Conrad PW, Roberts WC, et al. Hemochromatosis heart disease: an unempha-sized cause of potentially reversible restrictive cardiomyopathy. Am J Med 1980;69:923-8.
15. Finch CA, Ragan HA, Dyer IA, Cook JD. Body iron loss in animals. Proc Soc Exp Biol Med 1978;159:335-8.
16. Bothwell TH, Charlton RW, Cook JD, Finch CA, eds. Iron metabolism in man. Oxford, UK: Blackwell, 1979.
17. Carthew P, Dorman BM, Edwards R, Francis JE, Smith AG. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 1993;69:217-22.
18. Yang T, Dong WQ, Kuryshev YA, Obejero-Paz C, Levy MN, Brittenham GM, et al. Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med 2002;140:263-71.
19. Fiorillo A, Farina V, D'Amore R, Scippa L, Cortese P, DeChiara C. Longitudinal assessment of cardiac status by echocardiographic evaluation of left ventricular diastolic function in thalassemic children. Acta Paediatr 2000;89:436-41.
20. Hahalis G, Manolis AS, Gerasimidu I, Alexopoulos D, Sitafidis G, Kourakli A, et al. Right ventricular diastolic function in beta-thalassemia major: echocardiographic and clinical correlates. Am Heart J 2001;141:428-34.
21. Suarez WA, Snyder SA, Berman BB, Brittenham GM, Patel CR. Preclinical cardiac dysfunction in transfusion-dependent children and young adults detected with low-dose dobutamine stress echocardiography. J Am Soc Echocardiogr 1998;11:948-56.
22. Kuryshev YA, Brittenham GM, Fujioka H, Kannan P, Shieh CC, Cohen SA, et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes: implications for the arrhythmogenesis of human siderotic heart disease. Circulation 1999;100:675-83.
23. Obejero-Paz CA, Yang T, Dong WQ, Levy MN, Kuryshev YA, Brown AM. Deferoxamine promotes survival and prevents ECG abnormalities in iron-overloaded cardiomyopathy. J Lab Clin Med 2003;141:121-30.
24. Vermeulen JT. Mechanisms of arrhythmias in heart failure. J Cardiovasc Electrophysiol 1998;9:208-21.
25. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 2001;51:681-90.
26. Rosenbaum DS, Jalife J, eds. Optical mapping of cardiac excitation and arrhythmias. New York, NY: Futura Publishing, 2001.
27. Laurita KR, Rosenbaum DS. Interdependence of modulated dispersion and tissue structure in the mechanism of unidirectional block. Circ Res 2000;87:922-8.
28. Akar FG, Roth BJ, Rosenbaum DS. Optical measurement of cell-to-cell coupling in intact heart using subthreshold electrical stimulation. Am J Physiol Heart Circ Physiol 2001;281:H533-42.
29. Laurita KR, Girouard SD, Rosenbaum DS. Modulation of ventricular repolarization by a premature stimulus: Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea pig heart. Circ Res 1996;79:493-503.
30. Bayly PV, KenKnight BH, Rogers JM, Hillsley RE, Ideker RE, Smith WM. Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans Biomed Eng 1998;45:563-71.
31. Buja LM, Roberts WC. Iron in the heart: etiology and clinical significance. Am J Med 1971;51:209-21.
32. Chuck ET, Yang T, Kuryshev Y, Dong W, Rosenbaum DS, Brown AM, et al. Optical mapping reveals conduction abnormalities in iron-overloaded cardiomyopathic failing hearts [abstract]. J Cardiac Failure 2001;7:I-185.
33. Mattera R, Stone GP, Bahhur N, Kuryshev YA. Increased release of arachidonic acid and eicosanoids in iron-overloaded cardiomyocytes. Circulation 2001;103(suppl):2395-401.
34. Arnett EN, Neinheus AW, Henry WL, Ferrans VJ, Redwood DR, Roberts WC. Massive myocardial hemosiderosis: a structure-function conference at the National Heart and Lung Institute. Am Heart J 1975;90:777-87.
35. Capell DF, Hutchinson HE, Jowett M. Transfusional siderosis: the effects of excessive iron deposits in the tissues. J Pathol Bacteriol 1957;74:245-51.
36. Hauser SC. Hemochromatosis and the heart. Heart Dis Stroke 1993;2:487-91.
37. Kyriacou K, Michaelides Y, Senkus R, Simamonian K, Pavlides N, Antoniades L, et al. Ultrastructural pathology of the heart in patients with beta-thalassemia major. Ultrastruct Pathol 2000;24:75-81.
38. Sanyal SK, Johnson W, Jayalakshmamma B, Green AA. Fatal 'iron heart' in an adolescent: biochemical and ultrastructural aspects of the heart. Pediatrics 1975;55:336-41.
39. Schellhammer PF, Engle MA, Hagstrom JW. Histochemical studies of the myocardium and conduction system in acquired iron-storage disease. Circulation 1967;35:631-7.
40. Sonakul D, Thakerngpol K, Pacharee P. Cardiac pathology in 76 thalassemic patients. Birth Defects 1988;23:177-91.
41. Vigorita VJ, Hutchins GM. Cardiac conduction system in hemochromatosis: clinical and pathologic features of six patients. Am J Cardiol 1979;44:418-23.